ERNA Ernexa Therapeutics Inc.: institutional ownership and insider trading
10 funds reported holding $249K of Ernexa Therapeutics Inc. in their latest 13F filings; in Q2 2026 funds net bought $236K, with 9 new positions and 0 funds selling out; over the last 12 months insiders bought $2.00M and sold $0 on the open market.
ERNA revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$4.01M, EPS -3.40
- Quarter ended Mar 31, 2026: revenue n/a, net income −$5.51M, EPS -6.95
- Quarter ended Dec 31, 2025: revenue n/a, net income −$1.50M, EPS 70.86
- Quarter ended Sep 30, 2025: revenue n/a, net income −$1.24M, EPS -0.15
Famous investors holding ERNA
- Ken Griffin (Citadel Advisors): $100K, 0.0% of the portfolio
Largest institutional holders of ERNA
- CITADEL ADVISORS LLC — $100K
- VANGUARD FIDUCIARY TRUST CO — $55.4K
- Dauntless Investment Group, LLC — $39.9K
- VANGUARD CAPITAL MANAGEMENT LLC — $37.8K
- Tradewinds Capital Management, LLC — $14.7K
- BlackRock, Inc. (BLK) — $219
- ASSETMARK, INC — $16
- BNP PARIBAS FINANCIAL MARKETS — $7
- SBI Securities Co., Ltd. — $3
Recent ERNA insider trades
- Feb 10, 2026: Cherington Charles bought 4,000,000 shares ($2.00M)
- Jun 9, 2025: Cherington Charles bought 21,241,163 shares ($2.12M)
- Apr 2, 2025: Cherington Charles bought 3,768,397 shares ($377K)
5%+ owners
- Freebird Partners LP: 9.9% (Schedule 13G/A, filed May 15, 2026)
- Shameek Konar: 9.7% (Schedule 13G/A, filed May 13, 2026)
- John D. Halpern: 5.6% (Schedule 13G/A, filed May 15, 2026)
Who owns the most ERNA stock?
The largest institutional holders of Ernexa Therapeutics Inc. in the latest 13F filings are CITADEL ADVISORS LLC ($100K), VANGUARD FIDUCIARY TRUST CO ($55.4K), Dauntless Investment Group, LLC ($39.9K).
Are insiders buying or selling ERNA?
Over the last 12 months insiders bought $2.00M and sold $0 of Ernexa Therapeutics Inc. stock on the open market (SEC Form 4).
Which famous investors own ERNA?
Ken Griffin.